The DPP-4 inhibitors are a widely used class of drug to help manage blood glucose levels in patients with type 2 diabetes. But how were they discovered? In the following presentation, Dr Edwin Villhauer describes the journey he took with Novartis to discover vildagliptin, the first DPP-4 inhibitor.
Please provide feedback on these videos by scoring each question in the panel below on a scale from 0 to 10, where 0 is least and 10 is most.
Alternatively login via
Back to epgonline.org